Cite Filings / TCRX
Feed Companies Filings Check
Sign in

CIK 0001783328 · <br>Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825282075
Phone
857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Filings Insiders Search text
All 336 Financials 89 Shareholder Meetings 8 Executive Compensation 78 Insider Trading 119 Beneficial Ownership Interest 49 Business Combinations 66 Public Offerings 40 Mutual Funds and ETFs 6 Others 37
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-10-26
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-10-16
  4. DEF 14A Proxy Proxy Statement 2026-04-17
  5. PRE 14A Proxy Proxy Statement (Preliminary) 2026-04-07
  6. DEF 14A Proxy Proxy Statement 2025-05-14
  7. DEF 14A Proxy Proxy Statement 2024-04-30
  8. DEF 14A Proxy Proxy Statement 2023-04-25
  9. DEF 14A Proxy Proxy Statement 2022-04-21

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…